XML 153 R110.htm IDEA: XBRL DOCUMENT v3.24.1
Details of Significant Accounts - Recapitalization, schedule of listing expense (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Oct. 28, 2022
Oct. 27, 2022
Dec. 31, 2022
Dec. 31, 2023
Reverse Recapitalization        
Net assets of Provident at Closing, excluding the impact of PIPE and FPA investors     $ 63  
Cash and cash equivalents     7,893  
Accrued expenses     (500)  
Warrant liabilities (Note i)     (7,330)  
Total value of Perfect shares issued to Provident shareholders, excluding PIPE and FPA Investor (Note ii)     (56,478)  
Adjustment to listing expense as result of Sponsor Earnout     (8,849)  
Listing expense     (65,264)  
Non-current warrant liabilities     3,207 $ 1,566
Warrant liabilities        
Reverse Recapitalization        
Non-current warrant liabilities     8,431 8,431
Forward Purchase Agreements        
Reverse Recapitalization        
Warrant liabilities (Note i)     $ 7,330  
Number of shares issued (in shares) 6,764 5,500 5,500  
Share price per share (in USD per share) $ 8.35      
Forward Purchase Agreements | Warrant liabilities        
Reverse Recapitalization        
Non-current warrant liabilities       $ 8,431